Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 23, 2023Virtual Press Office and PR Newswire: General Trade show news
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Barcelona, Spain...
-
Oct 23, 2023Virtual Press Office and PR Newswire: General Trade show news
Bici Expo México, the premier professional bicycle exhibition in the region, took place from October 13th to 15th, 2023 at Mexico World Trade Center. Among the exhibitors, DAHON, the renowned...
-
Oct 23, 2023Virtual Press Office and PR Newswire: General Trade show news
GUANGZHOU, China, Oct. 23, 2023 /PRNewswire – The 134th Canton Fair is proud to celebrate the Double Ninth Festival, in gratitude and respect for the elderly, by showcasing its revamped Bathroom...
-
Oct 23, 2023Virtual Press Office and PR Newswire: General Trade show news
Infinity Laboratories is thrilled to officially unveil its new brand identity at the AAPS 2023 PharmaSci 360 Annual Meeting from October 22nd to the 25th in Orlando, Florida. As the paramount...
-
Oct 22, 2023Virtual Press Office and PR Newswire: General Trade show news
The IDF Dairy Innovation Awards winners were officially announced at the 2023 World Dairy Summit held from October 16 to 19 in Chicago. Yili Group was the sole global dairy company honored with...
-
Oct 22, 2023Virtual Press Office and PR Newswire: General Trade show news
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome drug resistance for hard-to-treat solid tumors, announces that clinical data of...
-
Oct 22, 2023Virtual Press Office and PR Newswire: General Trade show news
American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study results versus FIT at ACG High specificity...
-
Oct 22, 2023Virtual Press Office and PR Newswire: General Trade show news
– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy – – Enfortumab vedotin plus pembrolizumab improved median overall...
-
Oct 22, 2023Virtual Press Office and PR Newswire: General Trade show news
The ORR (objective response rate) and the DCR (disease control rate) in the frontline setting of glecirasib (KRAS G12C Inhibitor) in combination with JAB-3312 (SHP2 inhibitor) were 65.5% (38/58)...
-
Oct 21, 2023Virtual Press Office and PR Newswire: General Trade show news
Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion...